Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Why the 5% additional dilution since the 10K filing?!

I suppose that would be a relatively simple explanation, but unfortunately, if you reveiw the agreement, there does not seem to be anything that would trigger such an initial transfer. All of the transfers seem to be "at closing", not before.



http://www.sec.gov/Archives/edgar/da...

Share
New Message
Please login to post a reply